Eli Lilly’s $35 cap of one of its insulin drugs was about 100 years in the making. By today’s standards, it’s a huge step toward affordability of the life-saving drug. By historical standards, it’s long overdue. (The original patent for insulin was sold for a few bucks in the 1920s with the public’s interests in…
